Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Safety Evaluation of Nivolumab Concomitant With Platinum-Based Chemoradiation therapy for Intermediate and High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504 Gillison, M., Ferris, R. L., Zhang, Q., Colevas, A. D., Mell, L. K., Kirsch, C., Moore, K. L., Truong, M. T., Kong, C. S., Jordan, R., Clump, D. A., Ohr, J., He, K., Blakaj, D., Deeken, J., Machtay, M., Curran, W. J., Harris, J., Le, Q. T. ELSEVIER SCIENCE INC. 2018: 1307–8
View details for Web of Science ID 000428145600042